NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine -

Five ways to bust pharma ghostwriting in medical, science journals

Posted By



See William Heisel’s column that offers advice to journal editors and to journalists. He writes:

“Investigative journalists uncovered a series of scandals in recent years that have revealed the huge role that drug and device companies play in manipulating journal publications and continuing medical education programs through ghostwriting, speaking fees and other gun-for-hire arrangements.

Journal editors, though, have been slow to respond. No journal has stepped up to say, “We have investigated the extent of industry influence on the research in our journal and here is what we found.” Absent that, patients worldwide are left to wonder whether the drug they are being prescribed, the device being implanted in their body or the advice they are being given by their physician is based on strong science.”

You might also like


Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Dr. Lawrence Kindo

May 4, 2010 at 5:23 am

I believe this kind of practice is not new but has found new takers in the medical industry. The company get the prescription and authentication, the doctor or investigator gets the moolah. I hope that more detailed investigations are done prior to publication. I know that would prove to be an expensive affair. But, what other choice do we have?